← All stocks

Definium Therapeutics, Inc.

DFTX Scheduled selling only

CIK 0001813814 #1221 in the set updated 21 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$5.13M

$5.13M on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 15 sales

Net

−$5.13M

$0.00 against sales at will

By person

12 insiders · 17 transactions

130×

Robert Barrow holds 130 times base salary in stock. $85.16M of shares against $655.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Robert Barrow last reported holding, valued at $37.94, the price Common Shares was last bought or sold at on the open market here, on 3 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Barrow Robert

Chief Executive Officer

—

$3.08M (5) scheduled

−$3.08M

2,244,640

1.67%

$85.16M

+814.4%

Sullivan Mark

Chief Legal Officer

—

$1.04M (4) scheduled

−$1.04M

508,279

0.3783%

$19.28M

+798.7%

Karlin Daniel

Chief Medical Officer

—

$748.86K (4) scheduled

−$748.86K

803,699

0.5981%

$30.49M

+305.4%

Roberts Brandi

Chief Financial Officer

—

$135.68K (1) scheduled

−$135.68K

397,905

0.2961%

$15.10M

+43,245%

Wiley Matthew T.

Chief Commercial Officer

—

$129.10K (1) scheduled

−$129.10K

362,133

0.2695%

$13.74M

—

Liao Carrie

Chief Accounting Officer

—

144,923

0.1079%

$5.50M

+42.2%

CRYSTAL ROGER

Director

—

24,289

0.0181%

$921.52K

+23.8%

Bruhn Suzanne Louise

Director

—

24,289

0.0181%

$921.52K

+23.8%

Vallone Carol A

Director

—

22,296

0.0166%

$845.91K

+34.8%

Krebs Andreas

Director

—

21,402

0.0159%

$811.99K

+41.7%

GRYSKA DAVID W

Director

—

19,900

0.0148%

$755.01K

+56.3%

Adsett Roger

Director

—

3,555

0.0026%

$134.88K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 44

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 15

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 3,579,600

History held since 19 Jan 2022